The effects of drugs on barbiturate withdrawal convulsions in the rat.
D000818:Animals; D001463:Barbiturates; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D005013:Ethosuximide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D008781:Methyltyrosines / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D010649:Phenylalanine / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy; D012701:Serotonin / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D014364:Tryptophan / Q000627:therapeutic use
D001463:Barbiturates; D006834:Hydrazines; D006993:Hypnotics and Sedatives; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D011324:Primidone; D012701:Serotonin; D000431:Ethanol; D010649:Phenylalanine; D005013:Ethosuximide; D002707:Chlordiazepoxide; D009020:Morphine; D012110:Reserpine; D014364:Tryptophan; D008620:Meprobamate; D002746:Chlorpromazine